Citigroup maintains Intl Flavors & Fragrances at Buy, raises price target to $105 from $100

Citigroup maintained its Buy rating on Intl Flavors & Fragrances (IFF) and raised its price target to $105 from $100, citing a 21.6% upside from the Nov 5 close of $86.36. Recent analyst price targets for IFF range from $95 to $108.

Original reporting
Published Nov 5, 2026, 10:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 10:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Citigroup maintains Intl Flavors & Fragrances at Buy, raises price target to $105 from $100 — source image
Decision brief

The 30-second read

$IFFBullishLow
01

Why it matters

The upward revision signals confidence in IFF's near‑term performance, but without fresh company data the move is modest.

02

Market read

A small analyst upgrade that may prompt limited trading activity.

03

What to watch

No new earnings or operational data accompany the target change.

Relevance 4/10Novelty 3/10Timing: today

Background

Citigroup's rating action follows a series of recent analyst notes on IFF, with targets ranging $95‑$108.

Company-level read

Ticker impact

$IFFBullishMedium confidence
Context

Citigroup raised its price target on Intl Flavors & Fragrances to $105 from $100, indicating a fresh bullish outlook.

Expected impact

likely modest buying pressure as investors price in the higher target

Evidence & confidence

The new target implies a 21.6% upside from the recent close, which may attract short‑term interest.

Market effects

Minor impact on the flavors & fragrances sector as analysts adjust expectations.

Limited to U.S. equities where IFF trades.

Low global relevance.

Counterpoint

The target raise may be overly optimistic given broader market volatility.

Key entities

  • Intl Flavors & Fragrances

    Ticker IFF, a flavors and fragrances manufacturer.

  • Citigroup

    Equity research firm that raised the price target.

Related articles

$IFFMedAI 8/10

International Flavors & Fragrances Q3 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q3 sales of $566M in Health & Biosciences, up 1%. Full-year sales are expected to be $7.5B-$7.6B, with adjusted EBITDA of $1.55B-$1.6B. IFF faces cost pressures, particularly in Health & Biosciences, due to higher input costs. The company plans to divest its Food Ingredients business for $4.3B by mid-2027 and has completed other divestitures. Free cash flow for the first nine months of 2026 was $371M, up $245M year-over-year.

$IFFMed

International Flavors & Fragrances Inc (IFF) (Q3 2026) Earnings Call

International Flavors & Fragrances Inc (IFF) reported challenges in its Health business due to reduced consumer spending in the US and Europe. The company expects higher costs in Q4 2026, with net price to input costs remaining unfavorable. Profitability margins are expected to moderate due to seasonality and higher costs. IFF faces execution risks related to the separation of its Food Ingredients business.

$IFFHigh

BofA downgrades International Flavors & Fragrances stock rating on valuation concerns

BofA downgraded International Flavors & Fragrances (IFF) to Underperform, lowering its price target to $91. IFF reported Q3 adjusted EBITDA of $403M, beating estimates. Despite strong results, BofA cited valuation concerns, softness in non-Taste businesses, and rising costs. IFF's stock declined post-earnings due to near-term margin concerns, though management raised full-year guidance.

$IFFHighAI 8/10

Intl Flavors (IFF) Q3 2026 Earnings Call Transcript

Intl Flavors (IFF) reported Q3 2026 earnings with 5% revenue growth and 6% EBITDA increase, driven by strong performances in taste and scent segments. The company raised its full-year guidance, completed a $500M share repurchase, and announced strategic divestitures, including the sale of its food ingredients business for $4.3B. Free cash flow rose to $371M, up $245M YoY. IFF expects near-term softness in Health & Biosciences but remains confident in its growth strategy.

$IFFMedAI 9/10

IFF Q3 2026 slides: solid growth tempered by margin headwinds

International Flavors & Fragrances (IFF) reported Q3 2026 earnings with revenue of $1.94B and adjusted EPS of $0.83, beating expectations. Shares fell 3.83% due to margin concerns and guidance for softer Q4 profitability. IFF highlighted growth in Taste, Scent, and Health & Biosciences segments, along with a $4.3B sale of its Food Ingredients business and a $2.5B capital return program. Free cash flow improved to $371M, up $245M YoY.